Late Breaking Abstract - Oral formulation of angiotensin-(1-7) promotes resolution of eosinophilic and neutrophilic inflammation in an experimental asthma model

Conclusion: Therapeutic treatment with Ang-(1-7) at the peak of inflammation decreased eosinophil and neutrophil in a model of asthma induced by OVA and exacerbated by LPS.Support: FAPEMIG/FELUMA

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Vasconcellos, A. V., Gregorio, J., Oliveira, I., Ribeiro, A., Nakashima, G., Baroni, I., Barcelos, L., Santos, R., Campagnole-Dos Santos, M. J., Magalhaes, G., Rodrigues-Machado, M. D. G. Tags: Allergy and immunology Source Type: research